Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    European Union sees a 31.4% surge in fuel prices in September driven by key factors

    October 22, 2026

    Ultrasound Technique Significantly Strengthens Dissimilar Metal Welds for Enhanced Durability

    October 21, 2026

    European Union Allocates €3.4 Billion for 77 Innovative Net-Zero Technologies Based on New Funding Approach

    October 20, 2026
    Irish BriefIrish Brief
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Irish BriefIrish Brief
    Home » Your Trusted Bridge to MENA Regulatory Success and Market access for Pharma, Cosmetics, and Medical Devices
    Featured News

    Your Trusted Bridge to MENA Regulatory Success and Market access for Pharma, Cosmetics, and Medical Devices

    May 5, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Newszy: Dubai, UAE – As global pharmaceutical, cosmetic, and medical device companies set their sights on expanding into the rapidly growing MENA region, market momentum is stronger than ever. The GCC pharmaceutical sector alone was valued at $23.7 billion in 2024 and is projected to nearly double to $48.98 billion by 2033, with a CAGR of 7.6%. Likewise, the cosmetics market is expected to grow from $8.5 billion in 2024 to $14.4 billion by 2033, while the medical devices sector is set to rise from $17.15 billion in 2024 to $36.21 billion by 2035.  PRA Consultancy founded in 2013 as one of UAE pioneering healthcare regulatory consultancies, PRA Consultancy has successfully delivered over 10,000 projects, building a reputation for precision, speed, and unwavering reliability. With a remarkable 100% success rate in securing product registrations across the region, PRA Consultancy continues to turn complex regulatory requirements into seamless pathways for market access and sustained growth. Here’s how we help you thrive in this dynamic landscape:

    • Minimize Risk, Maximize Success: We reduce the risk of rejection by ensuring meticulous alignment with the latest health authority expectations.
    • Bridge the Cultural and Regulatory Gap: Our deep understanding of both global and regional frameworks eliminates delays and misalignment.
    • Clear Communication, No Misinterpretations: With multilingual experts on your side, we simplify complex guidelines and eliminate language barriers.
    • Local Insights, Strategic Entry: Our market intelligence and strong regional presence pave the way for smarter, faster decision-making.
    • Faster Registration, Smoother Approvals: We streamline timelines with precision planning and proactive follow-ups.
    • On-Ground Support You Can Trust: From licensing to representation, we handle the complexity so you can focus on growth.
    • Unified Strategy Across Borders: Our cross-country expertise ensures consistency, clarity, and compliance every step of the way.

    PRA solves these challenges with localized insight, multilingual professionals, and a proven methodology grounded in regional know-how and regulatory foresight.

    Full-Spectrum Regulatory Services

    PRA delivers bespoke support in:

    • Pharmaceutical Regulatory Affairs – Strategic advice, dossier preparation, and lifecycle management for drug products
    • Medical Device Compliance – Navigating classification, risk assessments, clinical evaluation, and CE-mark aligned submissions
    • Cosmetics & Aesthetic Regulatory Affairs – Ingredient assessments, product registration, labelling, and claims compliance
    • Biotech & Biopharma Compliance – Tailored regulatory solutions for novel therapies and biosimilars
    • F&B and Food Supplement Compliance – Ensuring safe and legal market entry for nutraceuticals and health-focused products
    • International Strategy – Harmonizing EU/FDA experience with MENA authority expectations

    Unmatched Market Access & Local Presence

    Whether helping a U.S. pharmaceutical brand launch in Saudi Arabia within three months, or enabling European cosmetic leaders to scale quickly across the GCC,
    PRA’s turnkey solutions and deep regulatory relationships deliver unmatched value. The consultancy acts as your local agent,
    managing the end-to-end regulatory process while allowing clients to retain flexibility with multiple distributors.

    Why Global Leaders Trust PRA

    • 100% regulatory approval track record
    • Multilingual, culturally aligned team
    • Comprehensive support across MENA & GCC
    • Time and cost-efficient strategies
    • Transparent, ethical, and multilingual workforce
    • Deep authority engagement and dynamic mapping of new guidelines
    • Capability to build regulatory departments from the ground up
    • Real-time mapping of guidelines and regulatory intelligence

    By bridging the cultural, linguistic, and regulatory divide, PRA Consultancy enables companies to launch faster, safer, and smarter with the confidence
    of knowing every guideline is correctly interpreted and every submission is strategically framed for success.

    Your Gateway to the MENA Region

    As global interest in MENA healthcare markets grows, PRA Consultancy is uniquely positioned to help international companies realize their expansion goals.
    From regulatory affairs for pharmaceutical products to cosmetics and medical device compliance, PRA transforms complexity into clarity.

    Contact: PRA Consultancy
    📍 Dubai, UAE
    🌐 www.pra-me.com
    ✉️ info@pra-me.com
    Tel: + 97142999398

    Related Posts

    MENA Newswire Expands Network with Eurasian Newswire

    October 15, 2026

    Dreame Rings Debut at Château de Chantilly in France, Opening a New Chapter of Pre-sales in Europe and Global Cooperation

    June 4, 2026

    Newszy relaunches managed PR distribution platform

    June 3, 2026

    Belvilla Deepens Its Commitment to the Netherlands Holiday Market Through Strategic Partnership with Luten Makelaardij

    April 29, 2026

    Belvilla and Flying Blue, Loyalty program of Air France-KLM partner to Expand Miles Redemption into Vacation Rentals

    April 20, 2026

    “Aqaar” and “Dusit International” Launch “Dusit Thani Residences Ajman” to Establish New Standards for Luxury Residential Communities in the Emirate

    February 13, 2026
    Latest News

    European Union sees a 31.4% surge in fuel prices in September driven by key factors

    October 22, 2026

    Ultrasound Technique Significantly Strengthens Dissimilar Metal Welds for Enhanced Durability

    October 21, 2026

    European Union Allocates €3.4 Billion for 77 Innovative Net-Zero Technologies Based on New Funding Approach

    October 20, 2026

    Bank of Italy’s 2026 Growth Projection Raised to 1% Amid External Risks

    October 19, 2026

    EU Implements New Anti-Trafficking Strategy Focused on Technology and Cross-Border Crime Networks

    October 17, 2026

    EU Implements Real-Time Schengen Alert System for Enhanced Terrorist Tracking

    October 16, 2026

    European Union Allocates €115 Million to Accelerate Defence Innovation through AGILE Initiative Focused on Emerging Technologies

    October 13, 2026

    UK enhances AI security protocols through advanced vulnerability assessments

    October 13, 2026
    © 2024 Irish Brief | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.